International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2017 - Volume 21, Number 3
View All Articles in Issue

Page(s): 233

Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, ketoconazole, formulation, antifungal agent, fungal infection, mycosis, candidiasis

Related Categories: FORMULATIONS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	May/Jun 2017 Pg. 233
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Ketoconazole 20-mg/mL Oral Suspension Allen Loyd V Jr	Mar/Apr 2017 Pg. 149
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Ketoconazole 25-mg Liquid Suppository Allen Loyd V Jr	Jul/Aug 2007 Pg. 329
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Allen Loyd V Jr	Nov/Dec 2016 Pg. 507
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Allen Loyd V Jr	Mar/Apr 2022 Pg. 142
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Basics of Compounding for Fungal Sinusitis Allen Loyd V Jr	Jul/Aug 2004 Pg. 289-291
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2020 Pg. 134
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 488
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O	Sep/Oct 2016 Pg. 426-434
Return to Top